{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:50:00Z","timestamp":1783039800605,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004375","name":"Tel Aviv University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Gestational diabetes mellitus (GDM) affects 3%\u201325% of pregnancies worldwide, posing risks to maternal, fetal, and neonatal health. GDM is often associated with macrosomia and large-for-gestational-age (LGA) infants. However, the association between GDM and small-for-gestational-age (SGA) infants is less understood. This study aimed to identify predictors of SGA in women with GDM.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective study included GDM patients (GDMA1 and A2) admitted to the fetal\u2013maternal unit between 2014 and 2023. The study population was divided into those who delivered an appropriate for gestational age (AGA) neonate and those who delivered an SGA neonate (defined as birthweight\u2009&lt;\u200910th percentile. Women with pregestational diabetes mellitus were excluded. Obstetric and neonatal outcomes were compared between the groups. A subgroup analysis focused on GDMA2 patients, comparing maternal and neonatal outcomes and treatment regimens (insulin and metformin use).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The study included 894 GDM patients. Compared to the AGA group (n\u2009=\u2009712), the SGA group (n\u2009=\u2009182) had lower maternal BMI (p\u2009=\u20090.02). Maternal age was comparable between groups. Rates of GDMA2 (30.2% vs. 23.4%, p\u2009=\u20090.07), and hypertensive disorders (7.1% vs. 5%, p\u2009=\u20090.21) did not differ significantly between the groups. The neonatal birthweight of the SGA infants was 2375\u2009\u00b1\u2009432\u00a0g vs. 3021\u2009\u00b1\u2009165\u00a0g in the AGA infants, (p\u2009=\u20090.005). The SGA group had a higher rate of CD due to NRFHR (27.4% vs. 18.4%, p\u2009&lt;\u20090.01). Among GDMA2 patients (n\u2009=\u2009222), more women in the SGA group (n\u2009=\u200955) were treated with metformin as compared to the AGA group (n\u2009=\u2009167) (72.7% vs. 23.9%, p\u2009&lt;\u20090.001). Multivariate regression analysis revealed that among GDMA2 patients metformin treatment was independently associated with SGA neonates OR 1.7, CI 1.18\u20131.35, p\u2009&lt;\u20090.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Metformin use in GDMA2 pregnancies may be linked to SGA neonates. The impact of metformin on fetal growth highlights the need for careful monitoring and individualized treatment strategies in managing GDMA2.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00404-025-08029-z","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T23:29:34Z","timestamp":1745278174000},"page":"445-450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of small-for-gestational-age infants in gestational diabetes mellitus: the impact of metformin use"],"prefix":"10.1007","volume":"312","author":[{"given":"Sivan","family":"Farladansky-Gershnabel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Lidsky-Sachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur","family":"Abd El Qadir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Biton Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tal","family":"Biron-Shental","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal","family":"Kovo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Ravid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"issue":"19","key":"8029_CR1","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1056\/NEJMoa0707193","volume":"358","author":"JA Rowan","year":"2008","unstructured":"Rowan JA, Hague WM, Gao W, Battin MR, Moore MP (2008) Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 358(19):2003\u20132015","journal-title":"N Engl J Med"},{"issue":"3","key":"8029_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.diabres.2012.09.031","volume":"98","author":"S Niromanesh","year":"2012","unstructured":"Niromanesh S, Alavi A, Sharbaf FR, Torabi R, Moosavi SG, Emdadi R, Habibollahi A (2012) Metformin compared with insulin in the management of gestational diabetes mellitus: a randomized clinical trial. Diabetes Res Clin Pract 98(3):333\u2013339","journal-title":"Diabetes Res Clin Pract"},{"key":"8029_CR3","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000439413","volume":"31","author":"C Spaight","year":"2016","unstructured":"Spaight C, Gross J, Horsch A, Puder JJ (2016) Gestational diabetes mellitus. Endocr Dev 31:163\u2013178","journal-title":"Endocr Dev"},{"issue":"Suppl 2","key":"8029_CR4","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000371628","volume":"66","author":"K Kc","year":"2015","unstructured":"Kc K, Shakya S, Zhang H (2015) Gestational diabetes mellitus and macrosomia: a literature review. Ann Nutr Metab 66(Suppl 2):14\u201320","journal-title":"Ann Nutr Metab"},{"issue":"4","key":"8029_CR5","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.ajog.2004.11.039","volume":"192","author":"O Langer","year":"2005","unstructured":"Langer O, Yogev Y, Most O, Xenakis EM (2005) Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol 192(4):989\u2013997","journal-title":"Am J Obstet Gynecol"},{"issue":"12","key":"8029_CR6","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1111\/dme.14266","volume":"37","author":"K Hilden","year":"2020","unstructured":"Hilden K, Magnuson A, Hanson U, Simmons D, Fadi H (2020) Trends in pregnancy outcomes for women with gestational diabetes mellitus in Sweden 1998\u20132012: a nationwide cohort study. Diabet Med 37(12):2050\u20132057","journal-title":"Diabet Med"},{"key":"8029_CR7","doi-asserted-by":"publisher","first-page":"1432033","DOI":"10.3389\/fpubh.2024.1432033","volume":"12","author":"Y Pan","year":"2024","unstructured":"Pan Y, Huang X, Jiang X (2024) Risk factors and prediction model for low birth weight infants born to women with gestational diabetes mellitus. Front Public Health 12:1432033","journal-title":"Front Public Health"},{"issue":"6","key":"8029_CR8","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/humrep\/deh263","volume":"19","author":"CJ Glueck","year":"2004","unstructured":"Glueck CJ, Goldenberg N, Pranikoff J, Sieve L, Wang P (2004) Height, weight, and motor-social development during the first 18 months of life in infants of metformin-treated women with polycystic ovary syndrome. Hum Reprod 19(6):1323\u20131330","journal-title":"Hum Reprod"},{"issue":"11","key":"8029_CR9","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.2337\/diacare.20.11.1717","volume":"20","author":"A Kautzky-Willer","year":"1997","unstructured":"Kautzky-Willer A, Prager R, Waldh\u00e4usl W, Pacini G, Thomaseth K, Wagner O (1997) Pronounced insulin resistance and inadequate \u03b2-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care 20(11):1717\u20131723","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"8029_CR10","doi-asserted-by":"publisher","first-page":"S282","DOI":"10.2337\/dc24-S015","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","unstructured":"American Diabetes Association Professional Practice Committee (2024) Management of diabetes in pregnancy: standards of care in diabetes. Diabetes Care 47(suppl 1):S282\u2013S294","journal-title":"Diabetes Care"},{"issue":"10","key":"8029_CR11","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","volume":"8","author":"DS Feig","year":"2020","unstructured":"Feig DS, Donoven LE, Zinman B et al (2020) Metformin in women with type 2 diabetes in pregnancy (MITY): a multicenter, international, randomized, placebo-controlled trial. Lancet Diabetes Endocrinol, Elsevier 8(10):834\u2013844","journal-title":"Lancet Diabetes Endocrinol, Elsevier"},{"issue":"2","key":"8029_CR12","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1097\/AOG.0000000000002501","volume":"131","author":"ACOG Practice Bulletins of Clinical Management Guidelines for Obstetrician-Gynecologists","year":"2018","unstructured":"ACOG Practice Bulletins of Clinical Management Guidelines for Obstetrician-Gynecologists (2018) ACOG Practice Bulletins NO. 190: Gestational diabetes mellitus. Obstet Gynecol 131(2):e49\u2013e64","journal-title":"Obstet Gynecol"},{"issue":"2","key":"8029_CR13","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1148\/radiology.150.2.6691115","volume":"150","author":"FP Hadlock","year":"1984","unstructured":"Hadlock FP, Harrist RB, Carpenter RJ, Deter RL, Park SK (1984) Sonographic estimation of fetal weight. the value of femur length in addition to head and abdomen measurements. Radiology 150(2):535\u2013540","journal-title":"Radiology"},{"key":"8029_CR14","doi-asserted-by":"publisher","first-page":"B2","DOI":"10.1016\/j.ajog.2018.01.041","volume":"218","author":"Society for Maternal-Fetal Medicine","year":"2018","unstructured":"Society for Maternal-Fetal Medicine (2018) DC.SMFM statement: pharmacological treatment of gestational diabetes. Am J Obstet Gynecol 218:B2\u2013B4","journal-title":"Am J Obstet Gynecol"},{"key":"8029_CR15","unstructured":"National Institute for Health and Care Excellence 2015 Diabetes in pregnancy: management of diabetes and its complications from preconception to the postnatal period. NICE guideline (NG3). London: National Institute for Health and Care Excellence (cited 2020 Feb 1)."},{"key":"8029_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h102","volume":"350","author":"M Balsells","year":"2015","unstructured":"Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R (2015) Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ 350:h102","journal-title":"BMJ"},{"issue":"27","key":"8029_CR17","first-page":"36","volume":"34","author":"S Butalia","year":"2017","unstructured":"Butalia S, Gutierrez L, Lodha A, Aitken E, Zakariasen A, Donovan L (2017) Short- and long-termoutcomes of metformin compared with insulinalone in pregnancy: a systematic review and meta-analysis. Diabet Med 34(27):36","journal-title":"Diabet Med"},{"issue":"5","key":"8029_CR18","doi-asserted-by":"publisher","first-page":"e1003126","DOI":"10.1371\/journal.pmed.1003126","volume":"17","author":"JL Tarry-Adkins","year":"2020","unstructured":"Tarry-Adkins JL, Aiken CE, Ozanne SE (2020) Comparative impact of pharmacological treatment for gestational diabetes on neonatal antrhropometry independent of maternal glycemic control: A systematic review and meta-analysis. PLOS Med 17(5):e1003126","journal-title":"PLOS Med"},{"issue":"11","key":"8029_CR19","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","volume":"17","author":"CJ Glueck","year":"2002","unstructured":"Glueck CJ, Goldenberg N, Wang P, Loftspring M, Sherman A (2002) Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone, and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception through pregnancy. Hum Reprod 17(11):2858\u20132864","journal-title":"Hum Reprod"},{"issue":"suppl 2","key":"8029_CR20","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.2337\/dc07-s216","volume":"30","author":"SL Kjos","year":"2007","unstructured":"Kjos SL, Schaefer-Graf UM (2007) Modified therapy for gestational diabetes using high risk and low risk fetal abdominal circumference growth to select strict versus relaxed maternal glycemic targets. Diabetes Care 30(suppl 2):S200\u2013S205","journal-title":"Diabetes Care"},{"key":"8029_CR21","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2337\/dc22-0013","volume":"45","author":"DS Feig","year":"2022","unstructured":"Feig DS, Zinman B, Asztalos E, Donovan LE, Shah PS, Sanchez J, Tomlinson G, Murphy KE (2022) Determinants of small for gestational age in women with type 2 diabetes mellitus in pregnancy: who should receive metformin? Diabetes Care 45:1532\u20131539","journal-title":"Diabetes Care"},{"issue":"6","key":"8029_CR22","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1097\/AOG.0b013e31823974e2","volume":"118","author":"MB Landon","year":"2011","unstructured":"Landon MB, Gabbe SG (2011) Gestational diabetes mellitus. Obstet Gynecol 118(6):1379\u20131393","journal-title":"Obstet Gynecol"},{"key":"8029_CR23","first-page":"CD012037","volume":"11","author":"J Brown","year":"2017","unstructured":"Brown J, Grzeskowiak L, Williamson K, Downie MR, Crowther CA (2017) Insulin for the treatment of women with gestational diabetes. Cochrane Database Syst Rev 11:CD012037","journal-title":"Cochrane Database Syst Rev"},{"issue":"27","key":"8029_CR24","first-page":"36","volume":"34","author":"S Butalia","year":"2017","unstructured":"Butalia S, Gutieerre L, Lodha A, Aitken E, Zakariasen A, Donoven L (2017) Short -and long term outcomes of metformin compared with insulin alone in pregnancy: a systematic review and meta-analysis. Diabet Med 34(27):36","journal-title":"Diabet Med"},{"key":"8029_CR25","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1124\/dmd.109.031245","volume":"38","author":"S Eyal","year":"2010","unstructured":"Eyal S, Easterling TR, Carr D, Umans JG, Miodovnik M, Hankins GD et al (2010) Pharmacokinetics of metformin during pregnancy. Drug Metab Disposition. 38:833\u2013840","journal-title":"Drug Metab Disposition."},{"key":"8029_CR26","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.ebiom.2018.08.047","volume":"35","author":"L Nguyen","year":"2018","unstructured":"Nguyen L, Chan SY, Teo AKK (2018) Metformin from mother to unborn child-are there un warranted effects? EBioMedicine 35:394\u2013404","journal-title":"EBioMedicine"},{"key":"8029_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.2337\/dci18-0055","volume":"42","author":"LA Barbour","year":"2019","unstructured":"Barbour LA, Feig DS (2019) Metformin for gestational diabetes mellites:progency, perspective, and a personalized approach. Diabetes Care 42:396\u2013399","journal-title":"Diabetes Care"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08029-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-025-08029-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-025-08029-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T11:44:57Z","timestamp":1757159097000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-025-08029-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,22]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["8029"],"URL":"https:\/\/doi.org\/10.1007\/s00404-025-08029-z","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,22]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}